Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775656 · ClinicalTrials.gov registry record
UCB Cimzia Pregnancy Follow-up Study
A clinical trial, sponsored by UCB Biosciences.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02775656: Clinical Trial study, sponsored by UCB Biosciences.
NCT02775656 is a clinical trial that was terminated before completion, run by UCB Biosciences. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02775656 was terminated before completion, sponsored by UCB Biosciences.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnancy.
Primary Outcome
The prevalence of major congenital malformations (MCMs) reported will be calculated by dividing the number of offspring with MCMs by the total number of live births and fetal losses with an MCM for all enrolled pregnancies and then stratified by treatment during pregnancy. The prevalence of MCMs will be calculated as soon as there are at least 50 prospectively-enrolled patients with an available outcome. Stillbirths and induced abortions (at 20 weeks gestation or greater) with reported MCMs are
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-12 |
Why NCT02775656 stopped before completion
NCT02775656 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02775656 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02775656 about?
NCT02775656 is a clinical study titled "UCB Cimzia Pregnancy Follow-up Study". The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or whose pregnancies have otherwise been reported to UCB due to potential CZP exposure during pregnanc...
What is the current status of trial NCT02775656?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2016-11. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02775656?
This trial is sponsored by UCB Biosciences, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia